Attached files
file | filename |
---|---|
EX-10.39 - ASSIGNMENT OF AGREEMENT, DATED AS OF APRIL 12, 2018, BY AND AMONG THE UNIVERSITY - AIkido Pharma Inc. | f10k2019ex10-39_spherix.htm |
EX-31.1 - CERTIFICATION - AIkido Pharma Inc. | f10k2019ex31-1_spherix.htm |
EX-21.1 - LIST OF SUBSIDIARIES - AIkido Pharma Inc. | f10k2019ex21-1_spherix.htm |
EX-23.1 - CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - AIkido Pharma Inc. | f10k2019ex23-1_spherix.htm |
10-K - ANNUAL REPORT - AIkido Pharma Inc. | f10k2019_spherixincorp.htm |
EX-10.40 - ASSIGNMENT OF AGREEMENT, DATED AS OF APRIL 17, 2018, BY AND AMONG WAKE FOREST UN - AIkido Pharma Inc. | f10k2019ex10-40_spherix.htm |
Exhibit 32.1
Certification
of
Principal Executive, Financial and Accounting Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Anthony Hayes, Director, Chief Executive Officer, Principal Financial and Accounting Officer of Spherix Incorporated (the “Company”), in compliance with Section 906 of the Sarbanes-Oxley Act of 2002, hereby certify that, to the best of my knowledge, the Company’s Annual Report on Form 10-K for the period ended December 31, 2019 (the “Report”) filed with the Securities and Exchange Commission:
Fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Anthony Hayes | |
Anthony Hayes | |
Chief Executive Officer | |
(Principal Executive Officer, | |
Principal Financial Officer and Principal Accounting Officer) | |
January 31, 2020 |
A signed copy of this written statement required by Section 906 has been provided to Spherix Incorporated and will be retained by Spherix Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.